Member Info for bakky

now Natdan, you've probably stoked up another 10 replies on the trot from mr greenbox...lol

yes LIon, even if we only get half a revolution and disruption we should be well into a double figure sp. The countdown clock is a bit of a laugh though. I've got confidence in SS, and he said they have/are working with Illumina, wonder what that could be?

lol. bet his party invites are rare..!!

sounds good to me.. Hope there is something 'material' to report around then. Congrats to Bhavika Patel on winning the young leader award at the Northern leadership awards 2022. Successor to LR one day maybe??

I think that's a bigger consideration than you think Frankie. After all it's why labs give out two tubes to start with. If plenty of labs start to adopt the EDTA then Streck tube manufacturers won't be very happy I guess.

agreed! cost savings will be the key, however they totally converted one lab onto Ygen's systems not knowing about the cost savings at the time. Just happy to get the better accuracy. So that says a lot knowing customers will adopt just for the accuracy alone. So the key disruptors are;
1; Better accuracy
2; smaller blood sample needed
3; much cheaper EDTA tubes (needs only one , not two Streck tubes)
Any more anyone can think of?

Did you see the CMD presentation? I think there is enough evidence there to show it's real and works according to the likes of Labcorp and a few very credible uni's.. No problems on that score !

not sure what your point in other than you think Ranger is all a fraud!?

apart from the obvious cost saving on the tubes !

so how and who will it disrupt? What is the 'revolution' game changer exactly?

When you come out with things like 'disruptive' and 'revolution' then it had better be bloody good! Does anyone know exactly who and how this 'disrupts'? Is it Illumina, TF and will it disrupt their expensive machinery sales. Is it Streck tubes, where the EDTA tubes will win out, or maybe both?

be pointless selling now if they reckon they are on the cusp of disruptive tech . Just need to prove it now, and if it's as good as they say, then there will be more than one interested party I feel. It's good to hear independents like Labcorp, Laval uni etc confirming that Ranger is indeed very good.
I think the summer was mentioned, not long to wait then?

employees/insiders selling out for their small overnight gain no doubt?

'making a step change in how we work with Nipt providers'. 'The traditional lab/manufacturer relationship is outdated, and doesn't reflect our patient centric vision'. So, more partnerships is the way forward, at least for Nipt anyway.

I think the market realises that covid revenue won't be replaced, in the short term at least. I think it needs to see good growth in the states. and they are very well positioned for that . They also need to get on quickly with cost savings, which I believe they are doing. I agree, the oncology sector could well be huge too! Labcorp seem very happy with the Ranger tech, and rightly so, more will follow no doubt.

No no, just that things are on the up, and rubber stamped credibility by the outfits that they are involved with. They simply would not entertain being involved with Ygen if the Ranger tech was no good, let alone everything else Ygen brings to the table with DPYD,NIPT etc.
EKF will be selling our products too very soon, if they are not already!

LR didn't buy 1M shares for nowt. 7p was the very bottom imo! I reckon anyone buying in now will make good money this year.

There are enough clues in the last presentation!

could it be a blue day...Is the ' disruptive revolution' on it's way?? You better believe it ... lol

Tbh, LR isn't reducing staff as quickly as I had hoped. Expected more of the muppets to appear here with their nonsense by now...Sour grapes at work methinks!! Pinch of salt and all that !